Cover Image
市場調查報告書

骨質缺乏症、骨質疏鬆症:主要13個國家的市場預測

Epiomic Epidemiology Series: Osteopenia & Osteoporosis Forecast in 13 Major Markets 2017-2027

出版商 Black Swan Analysis 商品編碼 444574
出版日期 內容資訊 英文 84 Pages
訂單完成後即時交付
價格
Back to Top
骨質缺乏症、骨質疏鬆症:主要13個國家的市場預測 Epiomic Epidemiology Series: Osteopenia & Osteoporosis Forecast in 13 Major Markets 2017-2027
出版日期: 2017年02月01日 內容資訊: 英文 84 Pages
簡介

本報告提供全球主要13個國家)的骨質缺乏症、骨質疏鬆症罹患數相關分析,疾病概要和目前的患病人數、 及性別、各年代 (5歲區分) 的詳細情況,各地區、各民族趨勢,風險要素,疾病診斷預後,主要的症狀和併發症,未來趨勢預測 (今後10年份)的資訊彙整,為您概述為以下內容。

目錄

  • 圖表一覽
  • 簡介
  • 疾病的原因
  • 風險要素與預防法
  • 疾病診斷方法
  • 各地區/各民族的差異
  • 疾病的預後和臨床過程
  • Frax(骨折風險評估工具)
  • 疾病相關的主要的共生病症/特徵
  • 患者數的測量方法
  • 骨質疏鬆症的最大患病人數
  • 骨質疏鬆症患者的特徵
    • 心臟血管疾病及代謝疾病的併發
    • 關節炎
    • 呼吸疾病併發
  • 骨質缺乏症的最大患病人數
  • 文中的簡稱一覽
  • Black Swan Analysis的其他出版刊物
  • Black Swan Analysis的線上、病患人數的資料庫
  • 病患人數的服務
  • 線上價格資料/平台
  • 參考文獻
  • 附錄

分析觀察對象國家

  • 澳洲、巴西、加拿大、中國、法國、德國、印度、義大利、日本、俄羅斯、西班牙、英國、美國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: OSTP0010217

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Osteopenia and Osteoporosis in13 Major Markets

Osteopenia and osteoporosis ("porous bone") are both terms which help to define the continuum of loss of bone density which leads to bone fragility and an increased risk of fractures of the hip, spine and wrist.

Loss of bone density is characterised by too little bone formation, excessive bone loss or a combination of both, typically as a result of hormonal changes, or deficiency of calcium or vitamin D.

Both osteopenia and osteoporosis remain largely under diagnosed because of their asymptomatic nature, especially in the less severe stages of bone loss.

This report provides the current prevalent population for Osteopenia and Osteoporosis across 13 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Brazil, Japan, India, China, Russia and Australia) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Osteopenia and Osteoporosis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

The following conditions and comorbidities are associated with loss of bone mineral density:

  • Back pain
  • Hypertension
  • Diabetes
  • Osteoarthritis
  • RA
  • COPD
  • CKD
  • Asthma
  • Hyperlipidaemia
  • Hyperthyroidism
  • Cushing's syndrome
  • Pituitary disease
  • Multiple myeloma
  • Thalassaemia major
  • AIDS/HIV
  • Bone fractures (particularly in the spine or hip)

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Osteopenia and Osteoporosis market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the prevalence of the subdivided types of Osteopenia and Osteoporosis as well as, identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Osteopenia and Osteoporosis prevalent population.
  • Identify sub-populations within Osteopenia and Osteoporosis which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Osteopenia and Osteoporosis patients.

Table of Contents

  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Frax
  • Key comorbid conditions/Features associated with the disease
  • Methodology for quantification of patient numbers
  • Top-line prevalence for Osteoporosis
  • Features of Osteoporosis patients
    • Cardiovascular and metabolic comorbidities
    • Arthritis in patients with osteoporosis
    • Respiratory comorbidities
    • Severe Osteoporosis patients
  • Top-line prevalence for Osteopenia
  • Abbreviations used in the report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix

List of Tables

  • Prevalence of osteoporosis, total (000s)
  • Prevalence of osteoporosis, males (000s)
  • Prevalence of osteoporosis, females (000s)
  • Osteoporosis patients with back pain, total (000s)
  • Osteoporosis patients with hypertension, total (000s)
  • Osteoporosis patients with hyperlipidaemia, total (000s)
  • Osteoporosis patients with hyperthyroidism, total (000s)
  • Osteoporosis patients with diabetes, total (000s)
  • Osteoporosis patients with osteoarthritis, total (000s)
  • Osteoporosis patients with rheumatoid arthritis, total (000s)
  • Osteoporosis patients with COPD, total (000s)
  • Osteoporosis patients with asthma, total (000s)
  • Severe osteoporosis patients, total (000s)
  • Site of fracture in severe osteoporosis patients, total (000s)
  • Osteoporosis patients with wrist fractures, total (000s)
  • Cause of fracture, total (000s)
  • Prevalence of osteopenia, total (000s)
  • Prevalence of osteopenia, males (000s)
  • Prevalence of osteopenia, females (000s)
  • Abbreviations and Acronyms used in the report
  • USA Prevalence of osteoporosis by 5-yr age cohort, males (000s)
  • USA Prevalence of osteoporosis by 5-yr age cohort, females (000s)
  • Canada Prevalence of osteoporosis by 5-yr age cohort, males (000s)
  • Canada Prevalence of osteoporosis by 5-yr age cohort, females (000s)
  • France Prevalence of osteoporosis by 5-yr age cohort, males (000s)
  • France Prevalence of osteoporosis by 5-yr age cohort, females (000s)
  • Germany Prevalence of osteoporosis by 5-yr age cohort, males (000s)
  • Germany Prevalence of osteoporosis by 5-yr age cohort, females (000s)
  • Italy Prevalence of osteoporosis by 5-yr age cohort, males (000s)
  • Italy Prevalence of osteoporosis by 5-yr age cohort, females (000s)
  • Spain Prevalence of osteoporosis by 5-yr age cohort, males (000s)
  • Spain Prevalence of osteoporosis by 5-yr age cohort, females (000s)
  • UK Prevalence of osteoporosis by 5-yr age cohort, males (000s)
  • UK Prevalence of osteoporosis by 5-yr age cohort, females (000s)
  • Brazil Prevalence of osteoporosis by 5-yr age cohort, males (000s)
  • Brazil Prevalence of osteoporosis by 5-yr age cohort, females (000s)
  • Japan Prevalence of osteoporosis by 5-yr age cohort, males (000s)
  • Japan Prevalence of osteoporosis by 5-yr age cohort, females (000s)
  • India Prevalence of osteoporosis by 5-yr age cohort, males (000s)
  • India Prevalence of osteoporosis by 5-yr age cohort, females (000s)
  • China Prevalence of osteoporosis by 5-yr age cohort, males (000s)
  • China Prevalence of osteoporosis by 5-yr age cohort, females (000s)
  • Russia Prevalence of osteoporosis by 5-yr age cohort, males (000s)
  • Russia Prevalence of osteoporosis by 5-yr age cohort, females (000s)
  • Australia Prevalence of osteoporosis by 5-yr age cohort, males (000s)
  • Australia Prevalence of osteoporosis by 5-yr age cohort, females (000s)
  • USA Prevalence of osteopenia by 5-yr age cohort, males (000s)
  • USA Prevalence of osteopenia by 5-yr age cohort, females (000s)
  • Canada Prevalence of osteopenia by 5-yr age cohort, males (000s)
  • Canada Prevalence of osteopenia by 5-yr age cohort, females (000s)
  • France Prevalence of osteopenia by 5-yr age cohort, males (000s)
  • France Prevalence of osteopenia by 5-yr age cohort, females (000s)
  • Germany Prevalence of osteopenia by 5-yr age cohort, males (000s)
  • Germany Prevalence of osteopenia by 5-yr age cohort, females (000s)
  • Italy Prevalence of osteopenia by 5-yr age cohort, males (000s)
  • Italy Prevalence of osteopenia by 5-yr age cohort, females (000s)
  • Spain Prevalence of osteopenia by 5-yr age cohort, males (000s)
  • Spain Prevalence of osteopenia by 5-yr age cohort, females (000s)
  • UK Prevalence of osteopenia by 5-yr age cohort, males (000s)
  • UK Prevalence of osteopenia by 5-yr age cohort, females (000s)
  • Brazil Prevalence of osteopenia by 5-yr age cohort, males (000s)
  • Brazil Prevalence of osteopenia by 5-yr age cohort, females (000s)
  • Japan Prevalence of osteopenia by 5-yr age cohort, males (000s)
  • Japan Prevalence of osteopenia by 5-yr age cohort, females (000s)
  • India Prevalence of osteopenia by 5-yr age cohort, males (000s)
  • India Prevalence of osteopenia by 5-yr age cohort, females (000s)
  • China Prevalence of osteopenia by 5-yr age cohort, males (000s)
  • China Prevalence of osteopenia by 5-yr age cohort, females (000s)
  • Russia Prevalence of osteopenia by 5-yr age cohort, males (000s)
  • Russia Prevalence of osteopenia by 5-yr age cohort, females (000s)
  • Australia Prevalence of osteopenia by 5-yr age cohort, males (000s)
  • Australia Prevalence of osteopenia by 5-yr age cohort, females (000s)

List of Tables

  • Normal vs. Osteoporotic bone
  • Postural changes associated with osteoporosis
Back to Top